HealthEquity, Inc. (NASDAQ:HQY) Receives $120.27 Consensus PT from Brokerages

by · The Cerbat Gem

Shares of HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seventeen brokerages that are presently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation, twelve have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $120.2667.

HQY has been the topic of several recent analyst reports. BTIG Research reiterated a “buy” rating and set a $130.00 target price on shares of HealthEquity in a research report on Thursday, December 4th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $120.00 target price on shares of HealthEquity in a research report on Friday, December 5th. Citizens Jmp boosted their price target on HealthEquity from $117.00 to $122.00 and gave the stock a “market outperform” rating in a research report on Thursday, December 4th. Royal Bank Of Canada lifted their price objective on shares of HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, September 3rd. Finally, Wall Street Zen cut shares of HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th.

View Our Latest Analysis on HealthEquity

HealthEquity Price Performance

HealthEquity stock opened at $92.69 on Friday. The stock has a market capitalization of $7.92 billion, a P/E ratio of 42.52, a P/E/G ratio of 1.36 and a beta of 0.18. HealthEquity has a 12-month low of $74.07 and a 12-month high of $116.65. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. The firm’s 50-day moving average is $97.21 and its two-hundred day moving average is $96.05.

HealthEquity (NASDAQ:HQY – Get Free Report) last posted its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The business had revenue of $322.16 million during the quarter, compared to analyst estimates of $320.92 million. During the same quarter in the previous year, the business posted $0.78 earnings per share. The company’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities analysts predict that HealthEquity will post 2.32 earnings per share for the current year.

Insiders Place Their Bets

In other HealthEquity news, EVP Elimelech Rosner sold 10,959 shares of the company’s stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $95.45, for a total value of $1,046,036.55. Following the completion of the transaction, the executive vice president directly owned 45,742 shares of the company’s stock, valued at $4,366,073.90. This represents a 19.33% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Michael Henry Fiore sold 1,781 shares of the firm’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the sale, the executive vice president owned 49,795 shares of the company’s stock, valued at $4,392,416.95. This represents a 3.45% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 17,240 shares of company stock worth $1,640,164 in the last quarter. 1.50% of the stock is owned by corporate insiders.

Institutional Trading of HealthEquity

Several institutional investors and hedge funds have recently bought and sold shares of the company. Norges Bank acquired a new position in shares of HealthEquity in the 2nd quarter worth approximately $75,072,000. Westfield Capital Management Co. LP raised its position in shares of HealthEquity by 124.6% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock valued at $132,543,000 after acquiring an additional 701,819 shares in the last quarter. AQR Capital Management LLC lifted its stake in HealthEquity by 148.5% during the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after purchasing an additional 661,795 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in HealthEquity by 995.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company’s stock worth $56,500,000 after purchasing an additional 580,988 shares during the period. Finally, Ameriprise Financial Inc. boosted its holdings in HealthEquity by 148.1% in the first quarter. Ameriprise Financial Inc. now owns 669,939 shares of the company’s stock worth $59,203,000 after purchasing an additional 399,897 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

(Get Free Report)

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

See Also